한국어
Quantus

PJ Electronics

006140 · KOSDAQ
₩4,750+2.15%
2026-09-04 close

PJ Electronics last closed at ₩4,750 (+2.15%) on 2026-09-04. Listed on KOSDAQ; price, financials and dividends update daily after market close.

Loading chart…
Close
No active signal.

New high + volume — the real recordrecord · not a prediction

Last 30 sessions
303 picks
Next-day win rate
50.7%
Avg next-day
-0.11%
vs market
-0.49%p

Every new-high-plus-volume pick we actually published (Korea market) — not this stock alone.

Signal history

DateSignal+20 trading days

A record, not a prediction.

How this is calculated

"·" means fewer than 20 trading days have passed since the event. Cup-and-handle entries are days our board actually showed the badge (archive grows daily since 2026-05-12); others are recomputed from price data.

Trade plan

Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.

A calculator · not advice or a guarantee

Financials & valuation at a glance

A
Overall: 건강관리 47/291 · top 16%
Factor composite · relative position in sector

PER 7.73 · PBR 0.54 — own-history percentile 91/100 · 100/100

Open self-history band
PER91/100
PBR100/100

Factual information · not investment advice

Past reported results · not investment advice

More — deeper indicators

Annual dividend

Split-adjusted annual DPS history and available grade axes

Annual dividend per share chart1994: 260원19941995: 125원1996: 540원1997: 55원1998: 55원1999: 66원2000: No dividend paid20002001: 18원2002: 27원2003: 46원2004: 55원2005: 100원20052006: 100원2007: 100원2008: 100원2009: 100원2010: 100원20102011: 100원2012: 100원2013: 100원2014: 133원2015: 133원20152016: 147원2017: 161원2018: 180원2019: 185원2020: 140원20202021: 100원2022: 130원2023: 100원2024: 120원2025: 180원180원2025
Annual dividend (per share · split-adjusted) · as of 2025
Consistency
A
Growth
B+
Yield
A-
Safety
A+
Reference indicatorView observed cut rates

Paid 25 consecutive years · Raised 2 consecutive years · Yield 3.79% (based on 2025 payment of 180원) · 3-year growth +11.5%

Per-share amount adjusted for splits and capital reductions · Factual information, not investment advice.

Financial safety

Reference indicatorAs of 2024
Safe zoneFinancial-metric reference signal
Altman Z'' zoneZ'' 6.05
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
6.05
Beneish M-Score
-3.00

No statistical flag

Sloan accrual
-6.22%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

8/9Strong

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score8/9

Profitability

  • Positive ROAPass
  • Positive OCFPass
  • Improving ΔROAPass
  • Accruals (OCF > net income)Pass

Leverage & liquidity

  • Lower debtPass
  • Higher current ratioPass
  • No new sharesPass

Efficiency

  • Higher gross marginPass
  • Higher asset turnoverNot passed

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Industry structure

KRAs of 2026-09-05

건강관리

This stock is in 건강관리: revenue rank 76 of 287, share 0.3%.

76 / 2870.3%revenue share

Who dominates this industry?

  1. 1삼성바이오로직스7.3%
  2. 2셀트리온5.7%
  3. 3녹십자홀딩스3.5%
  4. 4유한양행3.3%
  5. 5대웅3.1%
  6. 6피제이전자0.3%

Concentration

DistributedCR3 16.6%
HHI 202287 revenue members

HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.

Polarization

Winner-take-all deepeningConsistent

Polarization measures industry gaps and structure, not valuation, forecast, or investment advice.

Margin lens

IQR%p
31.61
Direction
확대
Level
넓음
Years
7

Value lens

P90/P10
13.9
Median P/B
1.47
Level
넓음
n
263

Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)

Factual information, not investment advice.

Risk sensitivity — adverse assumptions

Metric changes under stated assumptions; not a forecast or investment advice.

Base metrics

Operating margin
6.4%
Interest coverage
7.5x
Return on equity (ROE)
6.9%

Operating margin −5pp

Severe margin pressure
Interest coverageBase 7.5x adverse case 1.6x
Return on equity (ROE)Base 6.9% adverse case 0.7%

Revenue −15%

Tolerable
Interest coverageBase 7.5x adverse case 6.4x
Return on equity (ROE)Base 6.9% adverse case 5.8%

Interest rate +2pp

Tolerable
Interest coverageBase 7.5x adverse case 4.1x
Return on equity (ROE)Base 6.9% adverse case 6.2%

Interest coverage limit

Current margin 5.5pp

Interest coverage limit at an operating margin of 0.8%

Interest expense coverage threshold

Key suppliers · Annual report

Annual reportDART · 2026-03-16

Suppliers disclosed by the company in its 2026-03-16 annual report.

Suppliers without disclosed amount

GPSModuleEMSCOMExpressFrameAssyHDLTransistorsSMD

Who held it · filings

Filed record

A historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.

US 13F는 분기 공시이며 최대 45일 뒤 제출될 수 있습니다.

5%+ major-holding disclosures

  • 김재석69.86%2025-05-23 · 증감 -0.33%p

Connections

AI-extracted related companies · for reference

Customers
필립스GE HealthCare지멘스 헬시니어스후지필름올림푸스메드트로닉존슨앤드존슨
Competitors
로열 필립스GE HealthCare지멘스 헬시니어스
🔗 See in the full market map →

Recent filings

PJ Electronics's latest filings on Korea's DART. Open a headline for a reference summary and the original.

Source: DART (Korea electronic disclosure)

About PJ Electronics
What technical signals does PJ Electronics (006140) have?
PJ Electronics current technical signals: no active technical signal.
Is PJ Electronics a cup-and-handle pattern?
No. PJ Electronics has no valid cup-and-handle signal right now.
What are PJ Electronics's financials and valuation?
PJ Electronics's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Quantus Signal · live data · not investment advice · Privacy Policy